Abstract 10357: ARO-APOC3, an Investigational RNAi Therapeutic, Shows Similar Efficacy and Safety in Genetically Confirmed FCS and Non-FCS Participants with Severe Hypertriglyceridemia

Authors: Peter Clifton, David Sullivan, John Baker, Christian Schwabe, Susan Thackwray, Russell Scott, James Hamilton, Armando J Lira Pineda, Bruce Given, Stacey Melquist, Iris Chen, Javier San Martin, Gerald F Watts, Ira J Goldberg, Josh Knowles, Daniel Gaudet, Robert A Hegele, Christie M Ballantyne

Published: 2022-03-19

DOI: 10.1161/circ.144.suppl_1.10357

Source: Full article

---

Abstract

Background: